AZO Bladder Control with Go-Less® Blend Daily Supplement, Reduces Urgency & Leakage Naturally with 24-HR Support, 54 Count

AZO Bladder Control with Go-Less Reduce the urge to go to the bathroom with naturally-sourced ingredients like pumpkin seed extract.* Frustrated with how often you feel the urge to go to the bathroom? Tired of waking up in the middle of the night? There’s a better way. AZO Bladder Control with Go-Less is a safe, drug-free supplement that helps reduce the urge and supports bladder strength. This naturally-sourced blend will help you go less and worry less both day and night. AZO Bladder Control is derived from a naturally-sourced blend of pumpkin seed extract and soy germ. Pumpkin seed extract helps support bladder control by toning the muscles and maintaining the strength of the detrusor and sphincter muscles to promote normal function. Soy germ supports healthy control by sustaining the bladder muscle and pelvic floor. You may experience bladder health benefits in as little as two weeks, however your body may respond faster or slower, so give it up to 6 weeks to realize the full benefits. Adult.

• AZO BLADDER CONTROL WITH GO LESS: helps reduce occasional bladder leakage from laughing, coughing, sneezing, exercise
• AZO Bladder Control does what pads and liners can’t do: helps support bladder muscle strength and allows you to feel more confident to laugh without worry (adult)
• NATURALLY-SOURCED INGREDIENTS: AZO Bladder Control is sourced from pumpkin seed and soy germ
• Pumpkin seed extract helps support and maintain bladder muscle strength while soy germ extract helps relax the bladder and supports the muscles used to control the flow
• DRUG FREE AND GLUTEN FREE: Bladder Control with Go Less is drug-free too; making the use of panty liners, pads, or adult diapers simply optional, by promoting healthy bladder control
• *These statements have not been evaluated by The Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ◊As shown in an open-label study over 6 weeks.